We examined the effect of zinc on rat neuronal nicotinic acetylcholine receptors (nAChRs) expressed in Xenopus oocytes as simple heteromers of ␣2, ␣3, or ␣4 and ␤2 or ␤4. Coapplication of zinc with low concentrations of acetylcholine (ՅEC 10 ) resulted in differential effects depending on receptor subunit composition. The ␣2␤2, ␣2␤4, ␣3␤4, ␣4␤2, and ␣4␤4 receptors exhibited biphasic modulation by zinc, with potentiation of the acetylcholine response occurring at 1-100 M zinc and inhibition occurring at higher zinc concentrations. In contrast, ␣3␤2 receptors were only inhibited by zinc (IC 50 ϭ 97 Ϯ 16 M). The greatest potentiating effect of zinc was seen with ␣4␤4 receptors that were potentiated to 560 Ϯ 17% of the response to ACh alone, with an EC 50 of 22 Ϯ 4 M zinc. Cadmium, but not nickel, was also able to potentiate ␣4␤4 receptors. Both zinc potentiation of ␣4␤4 receptors and zinc inhibition of ␣3␤2 receptors were voltage independent. The sensitivity of zinc potentiation of ␣4␤4 to diethylpyrocarbonate treatment and alterations in pH suggested the involvement of histidine residues. Zinc continued to inhibit ␣4␤4 and ␣3␤2 after diethylpyrocarbonate treatment. Application of a potentiating zinc concentration increased the response of ␣4␤2 and ␣4␤4 receptors to saturating ACh concentrations. The rate of Ach-induced desensitization of these receptors was unaffected by zinc. Our results reveal zinc potentiation as a new mode of neuronal nAChR modulation.
Nicotinic acetylcholine receptors (nAChRs) are ligand-gated ion channels found at the neuromuscular junction and throughout the CNS and PNS. Neuronal nAChRs are similar to muscle nAChRs: they are formed as pentameric assemblies of subunits (Anand et al., 1991; Cooper et al., 1991) . To date, the neuronal nAChR subunit family consists of nine ␣ subunits (␣2-␣10) and three ␤ subunits (␤2-␤4) (Corringer et al., 2000) . These subunits can assemble, in exogenous expression systems, in various combinations to form receptors with varying functional and pharmacological properties (Role, 1992) . In the nervous system, neuronal nAChRs can form as pentameric homomers (such as ␣7 receptors) (Chen and Patrick, 1997; Drisdel and Green, 2000) , as simple heteromers composed of a single type of ␣ subunit and a single type of ␤ subunit (such as ␣4␤2 receptors) Flores et al., 1992) , or as complex heteromers of three or more subunits (such as ␣3␣5␤4 receptors) (Conroy and Berg, 1995) .
Ionic zinc has been found in neurons throughout the brain, with highest concentrations in the cerebral cortex and limbic areas (Frederickson et al., 2000) . Zinc is localized to small, clear vesicles in synaptic terminals and is released in a calciumdependent manner (Assaf and Chung, 1984; Howell et al., 1984) . The extracellular concentration of zinc is estimated to reach concentrations as high as 300 M (Assaf and Chung, 1984) . Zinc modulates the functions of members of several ligand-gated ion channel families, including glutamate, GABA, glycine, and ATP receptors (Mayer et al., 1989; Draguhn et al., 1990; Rassendren et al., 1990; Cloues et al., 1993; Bloomenthal et al., 1994; Paoletti et al., 1997; Krishek et al., 1998; Harvey et al., 1999; Xiong et al., 1999; Laube et al., 2000) . Both potentiation and inhibition of agonist-induced responses have been observed. The ability to modulate ligand-gated ion channel function suggests that zinc may be an important modulator of synaptic activity.
Relatively few studies have examined the effect of zinc on neuronal nAChRs. Zinc was shown to block ACh responses of rat intracardiac parasympathetic neurons (Nutter and Adams, 1995) . Zinc also attenuates the Ach-induced response of homomeric ␣7 nAChRs exogenously expressed in Xenopus oocytes (Palma et al., 1998) . We have now examined the effect of zinc on the several neuronal nAChRs that can be formed by pairwise expression of the ␣2, ␣3, or ␣4 subunits with the ␤2 or ␤4 subunits in Xenopus oocytes. We find that although all subunit combinations are inhibited by high concentrations of zinc, some subunit combinations are potentiated by low zinc concentrations (Յ100 M). Moreover, the extent of potentiation by zinc varies markedly depending on receptor subunit composition. Potentiation by zinc represents a new mode of neuronal nAChR modulation.
MATERIALS AND METHODS
Materials. Xenopus laevis frogs were purchased from Nasco (Fort Atkinson, W I). The care and use of X. laevis frogs in this study were approved by the University of Miami Animal Research Committee and meet the guidelines of the National Institutes of Health. RNA transcription kits were from Ambion (Austin, TX). Collagenase B was from Boehringer Mannheim (Indianapolis, I N). All other reagents were from Sigma (St. L ouis, MO).
Neuronal nAChR e xpression in X. laevis ooc ytes. m 7 G(5Ј)ppp(5Ј)Gcapped cRNA transcripts encoding nAChR subunits were prepared by in vitro transcription from linearized template DNA encoding the ␣2, ␣3, ␣4, ␤2, ␤4, ␣3-216-␣4, and ␣4 -216-␣3 subunits. Chimeric subunits were constructed previously (Harvey et al., 1996) . Mature X. laevis frogs were anesthetized by submersion in 0.1% 3-aminobenzoic acid ethyl ester, and oocytes were surgically removed. Follicle cells were removed by treatment with collagenase B for 2 hr at room temperature. Stage V oocytes were individually injected with 0.5-10 ng of each cRNA in 15-50 nl of water and incubated at 19°C in modified Barth's saline (88 mM NaC l, 1 mM KC l, 2.4 mM NaHC O 3 , 0.3 mM C aNO 3 , 0.41 mM CaCl 2 , 0.82 mM MgSO 4 , 100 g /ml gentamicin, 15 mM H EPES, pH 7.6) for 2-7 d.
Electrophysiolog ical methods. Current responses were measured under two-electrode voltage clamp, using a TEV-200 voltage-clamp unit (Dagan, Minneapolis, M N). Micropipettes were filled with 3 M KC l and had resistances of 0.3-2.0 M⍀. Current responses were sampled at 100 Hz and filtered (four-pole, Bessel low-pass) at 20 Hz. Current responses were captured, stored, and analyzed on a Macintosh Power PC 7100 computer using AxoData 1.2.2 and AxoGraph 4.0 software (Axon Instruments, Foster C ity, CA). All experiments were performed at a holding potential of Ϫ70 mV, except for voltage-dependence studies (see Fig. 7 ), ACh concentration -response experiments (see Fig. 8 ), and desensitization rate measurements. The ACh concentration -response experiments were performed at a holding potential of Ϫ40 mV to decrease current amplitudes at higher ACh concentrations and to minimize the contribution of the calcium-activated chloride channel to the ACh response. As demonstrated in Figure 7 , the Z n 2ϩ effect is independent of membrane holding potential. Desensitization rate measurements for ␣4␤4 and ␣4␤2 receptors were performed at Ϫ40 mV with Ba 2ϩ substituting for C a 2ϩ in all solutions to f urther minimize any contribution of the calcium-activated chloride channels. Each oocyte was exposed to an EC 50 concentration of ACh with or without 50 M Zn 2ϩ for 60 sec. The order of application was alternated from oocyte to oocyte. The desensitizing phase of each response was fit to a single exponential f unction.
Oocytes were perf used at room temperature (20Ϫ25°C) with perf usion solution (115 mM NaC l, 1.8 mM CaCl 2 , 2.5 mM KC l, 0.1 M atropine, 10 mM H EPES, pH 7.2) in a chamber constructed from 1/8 inch inner diameter T ygon tubing. Perf usion was continuous at a rate of ϳ20 ml /min. Agonists and metals were diluted in the perf usion solution and then applied to oocytes using solenoid valves. All experiments, except for desensitization rate measurements and experiments shown in Figs. 3 and 8, were performed as follows. ACh alone was applied for 30 sec, followed by a 30 sec application of solutions containing both ACh and the metal ion of interest, and then by 30 sec of ACh alone. Between applications, oocytes were perf used continuously. In cases in which no desensitization was evident (␣4␤4 responses in Figs. 1-7) , defined as a current decrease of Ͻ5% over 30 sec, control current in response to agonist was determined from a 1 sec average beginning 29 sec after initiation of agonist application. Current levels during metal coapplication were determined from a 1 sec average beginning 29 sec after initiation of metal application and compared with the control current. In cases in which desensitization was evident (all experiments involving ␣2␤2, ␣2␤4, ␣3␤2, ␣3␤4, and ␣4␤2), defined as a current decrease of Ͼ5% over 30 sec, the following analysis method was used. The initial 30 sec ACh response in the absence of metal was fit to a single or dual exponential and was projected over the next 30 sec in which both ACh and metal were coapplied. The degree of modulation was measured by taking a 1 sec average 29 sec after initiation of metal application and comparing it with a 1 sec average of the projected response to ACh alone at the same time period. Thus, both metal and control values were taken 59 sec after the initiation of the experiment.
For the ACh concentration -response experiments shown in Figure 8 , experiments were performed and measurements were taken as follows. Because receptor expression levels vary from oocyte to oocyte, it is necessary to normalize concentration -response data from different oocytes to allow comparison. However, desensitization makes the maximal response an unreliable standard with which to normalize data. For this reason we normalized each response to the response to a low concentration of ACh (3 M) that produced little or no desensitization. To compare and display the results we then renormalized the data to the fit maximal response to ACh alone. To determine the effect of Z n 2ϩ on the ACh concentration -response relationship we used our standard protocol (30 sec of ACh alone, followed by 30 sec of ACh ϩ Zn 2ϩ , followed by 30 sec of ACh alone), but with a normalizing ACh application interleaved between experimental applications. Data were then normalized to the immediately preceding application of 3 M ACh. We measured the effect of Z n 2ϩ in two ways. First, because most responses of both receptors showed appreciable desensitization, we measured the effect of Z n 2ϩ as described above for desensitizing receptors. Second, the peak response to Zn 2ϩ was compared with a 1 sec average of the response to ACh alone taken immediately before Z n 2ϩ application. Because both methods yielded similar results, only the results of the first method are plotted in Figure 8 .
Because neuronal nAChRs differ in their sensitivity to ACh, it is important to ensure that the effects of metal application are measured with ACh concentrations that elicit a similar fraction of the maximal response. Therefore, unless noted otherwise, all ACh concentrations were within a range from the EC 2 to the EC 10 for each receptor. ACh EC 2 and EC 10 values were calculated from data presented previously (Harvey et al., 1996) . Within this range, a single ACh concentration was used for each subunit combination (12 M for ␣2␤2, 15 M for ␣2␤4, 4 M for ␣3␤2, 17 M for ␣3␤4, 10 M for ␣4␤2, 1 M for ␣4␤4).
Z inc solutions used in all experiments shown in this study were prepared from zinc acetate stock solutions. To rule out an effect of the acetate, zinc concentration effect curves for the ␣3␤2, ␣4␤2, and ␣4␤4 receptors were replicated using Z nC l 2 with similar results (data not shown). In the absence of ACh, zinc concentrations Ͻ70 M had no effect on ␣4␤4-expressing, ␣3␤2-expressing, or uninjected oocytes. Z inc concentrations Ն70 M elicited small, slow, variable (inward and outward) currents. Because these currents were always Ͻ5% of ACh responses, they were disregarded in our analysis.
Diethylpyrocarbonate treatment of nAChR s. Diethylpyrocarbonate (DEPC) was diluted in perf usion solution immediately before application. Preliminary experiments determined that a 10 min incubation achieved a maximal DEPC effect (data not shown). During incubation, the DEPC solution was exchanged twice at regular intervals. After incubation, the DEPC was washed out of the chamber for an additional 10 min with perf usion solution. Electrophysiological measurements were taken before DEPC application and immediately after the 10 min washout period.
Data anal ysis. Data from metal concentration -response experiments for ␣2␤2, ␣2␤4, ␣3␤4, ␣4␤2, and ␣4␤4 receptors were analyzed as follows. Concentration -potentiation curves were fit according to the following equation for concentrations up to and including those concentrations of metals that achieved maximal potentiation: I ϭ I max /(1 ϩ (EC 50 /X ) n ), where I represents the current response at a given metal concentration, X; I max is the maximal current; EC 50 is the concentration of metal yielding half-maximal potentiation; n is the Hill coefficient. Concentration -inhibition curves were fit according to the following equation for concentrations of metals at or above those concentrations that achieved maximal potentiation: I ϭ I max /(1 ϩ (X/IC 50 ) n ), where I represents the current response at a given metal concentration, X; I max is the maximal current; IC 50 is the concentrations of metal yielding halfmaximal inhibition; n is the Hill coefficient. Because no potentiation was apparent for the ␣3␤2 receptor, the entire data set was fit with the concentration -inhibition equation.
The data presented in Figure 2 suggest that at some concentrations zinc may be exerting both potentiating and inhibiting effects on neuronal nAChRs. If this is true, then the maximal potentiation that we observe may be an underestimate. To examine this issue, we fit the zinc concentration -effect data to a more complex equation that included both a potentiating and an inhibitory site:
where I represents the current response at a given metal concentration, X; I min is the minimal current; I max is the maximal current; EC 50 and IC 50 are the concentrations of metal yielding half-maximal potentiation and inhibition, respectively; n and m are the Hill coefficients for potentiation and inhibition, respectively (Harvey et al., 1999) . Results of this analysis suggest that the maximal potentiation that we observe is indeed an underestimate. Fitting to this equation suggests that the true maximal potentiation is severalfold greater than what we observe. However, because the measured data covers only the lower portion of the putative f ull curve, we have reported only the results of fitting the potentiating and inhibiting data sets separately.
ACh concentration -response curves in Figure 8 were fit to the following equation: I ϭ I max /(1 ϩ (EC 50 /X ) n ), where I represents the current response at a given ACh concentration, X; I max is the maximal current; EC 50 is the concentration of ACh yielding half-maximal response; n is the Hill coefficient.
Prism software (GraphPad, San Diego, CA) was used to fit the data and to assess statistical significance using a two-tailed unpaired t test.
RESULTS

Zn
2؉ modulates neuronal nAChRs Simple heteromeric neuronal nAChRs consisting of one type of ␣ subunit (␣2, ␣3, or ␣4) and one type of ␤ subunit (␤2 or ␤4) were expressed in Xenopus oocytes. Current responses were recorded under two-electrode voltage clamp on application of ACh (at or below the EC 10 for each receptor) in the absence or presence of various concentrations of Zn 2ϩ . The effect of Zn 2ϩ varied depending on the subunit composition of the receptor. Zn 2ϩ application had a biphasic effect on ACh responses of ␣4␤2-expressing oocytes. Zn 2ϩ concentrations in the range of 1-100 M increased the inward current elicited by 10 M ACh (Figs. 1 A, In contrast to the biphasic effect of Zn 2ϩ on ␣4␤2 nAChRs, ␣3␤2 receptors exhibited only inhibition by Zn 2ϩ (Fig. 1 B, 2B) . Reduction in the current elicited by 4 M ACh occurred with Zn 2ϩ concentrations ranging from 1 M to 3 mM, with an IC 50 of 97 Ϯ 16 M. Zn 2ϩ concentrations Ն1 mM almost completely blocked the response to ACh. The loss of Zn 2ϩ potentiation on changing the ␣ subunit from ␣4 to ␣3 supports a role for the ␣ subunit in mediating potentiation.
To determine whether ␤ subunits also play a role in Zn 2ϩ potentiation of nAChRs, we examined the effect of Zn 2ϩ on the ␣3␤4 receptor (Fig. 2 B) . Current in response to 17 M ACh was potentiated to a maximum of 140 Ϯ 2% at 200 M Zn receptors, high concentrations of Zn 2ϩ inhibited the ␣3␤4 receptor (IC 50 ϭ 3200 Ϯ 1400 M Zn 2ϩ ). The ability of ␣4␤2 and ␣3␤4, and the failure of ␣3␤2 nAChRs, to be potentiated by Zn 2ϩ suggests that the ␣4 and ␤4 subunits are each capable of supporting Zn 2ϩ potentiation when they are present in a receptor. When both of these subunits were present in the same receptor (␣4␤4), the effect of Zn 2ϩ was dramatic (Figs. 1C, 2C ). The ␣4␤4 receptor was potentiated to a maximum of 560 Ϯ 17% at 100 M Zn 2ϩ , with an EC 50 of 22 Ϯ 4 M Zn 2ϩ . Again, higher concentrations of Zn 2ϩ were found to be inhibitory, with an IC 50 of 510 Ϯ 37 M Zn 2ϩ . The ␣2 subunit is highly homologous to the ␣4 subunit. As might be expected, ␣2␤2 and ␣2␤4 receptors were also potentiated by low Zn 2ϩ concentrations and inhibited by high Zn 2ϩ concentrations (Fig. 2 A; Table 1 ). When high concentrations of Zn 2ϩ are coapplied with ACh to some subunit combinations, the current responses can be complex. A good example can be seen when 3 mM Zn 2ϩ is coapplied to the ␣4␤4 receptor (Fig. 1C, bottom trace) . On coapplication of Zn 2ϩ , a rapid transient potentiation is seen, followed by a rapid decrease in the response. On removal of Zn 2ϩ , there is again a rapid potentiation of the current followed by a slow decline toward the response amplitude seen with ACh alone. These potentiation transients can be explained by considering the relatively slow fluid exchange rate in the perfusion chamber. When a high concentration of Zn 2ϩ is applied, the concentration of Zn 2ϩ in the chamber will pass through a concentration range that potentiates but does not inhibit the receptors, before reaching a final concentration that both potentiates and inhibits the receptors. Similarly, when Zn 2ϩ is withdrawn, the declining concentration in the chamber will again pass through a potentiating, but not inhibiting, concentration range. To determine whether this explanation is valid, we used a revised protocol in which Zn 2ϩ alone was applied to ␣4␤4-expressing oocytes first, followed by coapplication of Zn 2ϩ and ACh. With this protocol, the potentiation transients were eliminated (Fig. 3A) . The Zn 2ϩ concentration-effect relationship obtained with this modified protocol (Fig. 3B ) was similar to results presented in Figure 2C .
Modulation of nAChRs by cadmium and nickel
We explored the selectivity of the potentiation by examining the effect of additional transition metals on the ␣4␤4 receptor (Fig.  4) 
Potential involvement of histidine residues in mediating Zn 2؉ potentiation
Histidine residues are often involved in coordinating Zn 2ϩ at Zn 2ϩ binding sites. DEPC, under some conditions (pH Ն 6, low millimolar concentrations), can selectively modify the imidazole ring of histidine, eliminating its ability to coordinate Zn 2ϩ ions. We examined the effects of DEPC treatment on the ability of Zn 2ϩ to modulate ␣4␤4 and ␣3␤2 receptors (Fig. 5) . A 10 min incubation with DEPC concentrations ranging from 100 M to 3 mM had little effect on the response of ␣4␤4 receptors to ACh. Although treatment with 100 M DEPC had a minimal effect on potentiation by 100 M Zn 2ϩ (Fig. 5B) , treatment with 1 or 3 mM DEPC abolished the ability of Zn 2ϩ to potentiate the ␣4␤4 receptor (Fig. 5 A, B) . This result suggests the involvement of at least one histidine residue in mediating the potentiating effects of Zn 2ϩ on neuronal nAChRs. We examined the effect of 3 mM DEPC on modulation of ␣4␤4 receptors by a range of Zn 2ϩ concentrations (Fig. 5C ). Although potentiation was eliminated, Zn 2ϩ continued to inhibit ␣4␤4 receptors after DEPC treatment. DEPC (3 mM) also failed to affect Zn 2ϩ inhibition of ␣3␤2 receptors (Fig. 5D ). The ability of Zn 2ϩ to inhibit ␣4␤4 or ␣3␤2 after DEPC treatment suggests that the inhibitory site on these receptors may not involve histidine residues.
To provide further evidence that histidine residues are involved in mediating Zn 2ϩ potentiation of ␣4␤4, we examined the effect of altering the pH (Fig. 6) . At pH 5.5, the extent of potentiation by 100 M Zn 2ϩ was significantly reduced (180 Ϯ 9%) as compared with potentiation at pH 7.2 (our standard conditions). Increasing the pH to 8.0 resulted in a significant increase in the magnitude of the Zn 2ϩ effect (770 Ϯ 70%). These results are consistent with a role for one or more histidine residues in mediating the potentiating effect of Zn 2ϩ .
Zn
2؉ -mediated potentiation and inhibition of neuronal nAChRs are voltage independent
To assess the proximity of the Zn 2ϩ binding sites to the electrical field of the membrane, we examined potentiation of ␣4␤4 and inhibition of ␣3␤2 receptors over a range of holding potentials.
The potentiation of the ACh response of ␣4␤4 receptors by 50 M Zn 2ϩ was examined at several holding potentials ranging from Ϫ90 mV to Ϫ40 mV (Fig. 7B) . This Zn 2ϩ concentration was chosen to minimize any influence from the inhibition seen at higher Zn 2ϩ concentrations. The extent of potentiation was similar at all holding potentials tested (Fig. 7 A, B) . The degree of inhibition of ␣3␤2 nAChR current responses by 100 M Zn 2ϩ was also independent of the holding potential from Ϫ90 mV to Ϫ40 mV (Fig. 7B) .
Zn
2؉ potentiates the response of neuronal nAChRs to saturating acetylcholine concentrations
We examined the effect of Zn 2ϩ on the ACh concentrationresponse relationships of ␣4␤4 and ␣4␤2 receptors (see Materials and Methods). Again, 50 M Zn 2ϩ was chosen to provide potentiation with minimal inhibition. Zn 2ϩ coapplications significantly increased the response of ␣4␤4 to saturating ACh concentrations (160 Ϯ 11% of the response to ACh alone; p Ͻ 0.02) and significantly decreased the EC 50 for ACh activation from 74 Ϯ 22 ( p Ͻ 0.05) (Fig. 8 A) . Zn 2ϩ coapplication also significantly increased the response of ␣4␤2 to saturating ACh concentrations (140 Ϯ 14% of the response to ACh alone; p Ͻ 0.02) but had no significant effect on the apparent ACh affinity of ␣4␤2 (Fig. 8 B) .
Zn
2؉ does not alter receptor desensitization rate
One possible mechanism for Zn 2ϩ potentiation is through an effect on receptor desensitization. If Zn 2ϩ were to slow the desensitization rate of a receptor, an apparent potentiation of the agonist response would result. This possible mechanism seems unlikely to account for Zn 2ϩ potentiation of ␣4␤4, which can be dramatically potentiated even when no appreciable desensitization is evident (Fig. 1C) . However, to examine this issue in more detail, we measured the desensitization rate of ␣4␤4 and ␣4␤2 receptors when exposed to an EC 50 concentration of ACh in the absence and presence of 50 M Zn 2ϩ . Oocytes were held at Ϫ40 mV and Ba 2ϩ was substituted for Ca 2ϩ in all solutions to minimize the contribution of the Ca 2ϩ -activated Cl Ϫ channel (see Materials and Methods). For ␣4␤4, there was no difference between desensitization rate for ACh alone ( ϭ 88 Ϯ 13 sec) and the desensitization rate in the presence of Zn 2ϩ ( ϭ 77 Ϯ 17 sec) (n ϭ 6). For ␣4␤2, there was no difference between the desensitization rate for ACh alone ( ϭ 42 Ϯ 3 sec) and the desensitization rate in the presence of Zn 2ϩ ( ϭ 43 Ϯ 7 sec) (n ϭ 5). We conclude that Zn 2ϩ does not affect the rate of Ach-induced desensitization for these receptors.
Determinants of Zn
2؉ potentiation are only partially localized to the N-terminal extracellular domain We used chimeras of the ␣3 and ␣4 subunits to provide preliminary information regarding the location of amino acid residues involved in mediating Zn 2ϩ potentiation (Fig. 9) . The ␣4 -216-␣3 and ␣3-216-␣4 subunits each consist of the N-terminal extracellular domain of one subunit joined to the remainder of the other subunit. Each of the chimeras was coexpressed with the ␤4 subunit, and the resulting receptors were then examined for sensitivity to a range of Zn 2ϩ concentrations using our standard protocol (see Materials and Methods). Receptors in which the N-terminal extracellular domain of ␣4 has been replaced with the ␣3 sequence (␣3-216-␣4 ␤4) showed a dramatic loss in sensitivity to Zn 2ϩ potentiation. However, 170 Ϯ 5% potentiation at 100 M Zn 2ϩ was still significantly greater than the potentiation seen with ␣3␤4. Receptors in which the region of ␣4 containing the transmembrane and cytoplasmic domains has been replaced with the ␣3 sequence (␣4 -216-␣3 ␤4) also showed a loss in sensitivity to Zn 2ϩ potentiation when compared with ␣4␤4. However, with a maximal potentiation of 250 Ϯ 10% at 100 M Zn 2ϩ , the ␣4 -216-␣3 ␤4 receptors were potentiated to a greater degree than ␣3-216-␣4 ␤4 or ␣3␤4 receptors. These results suggest that although the most critical determinants of Zn 2ϩ potentiation are located in the N-terminal extracellular domain of ␣4, important residues also reside in the remainder of the subunit. 
DISCUSSION
We have demonstrated that neuronal nAChRs are modulated by Zn 2ϩ in a subunit-dependent manner. The ␣2␤2, ␣2␤4, ␣3␤4, ␣4␤2, and ␣4␤4 receptors are potentiated by low Zn 2ϩ concentrations (1-100 M) and inhibited by high concentrations of Zn 2ϩ (Ͼ100 M). In contrast, the ␣3␤2 receptors exhibit only inhibition of Ach-induced currents on Zn 2ϩ coapplication. Cd 2ϩ coapplication also modulated the ACh response of ␣4␤4 receptors in a biphasic manner, but potentiation by Cd 2ϩ was much less than that seen with Zn 2ϩ . A role for histidine residues in mediating Zn 2ϩ potentiation was suggested by the ability of DEPC to abolish potentiation of ␣4␤4 receptors and by the sensitivity of potentiation to alterations in pH. Zn 2ϩ coapplication potentiated the ␣4␤4 and ␣4␤2 receptors even at saturating ACh concentrations. However, Zn 2ϩ had no effect on the rate of Ach-induced desensitization of either receptor. Zn 2ϩ has been shown to act as a subtype-dependent modulator of other classes of ligand-gated ion channels such as ATP, GABA, glutamate, and glycine receptors (Mayer et al., 1989; Rassendren et al., 1990; Cloues et al., 1993; Bloomenthal et al., 1994; Krishek et al., 1998; Harvey et al., 1999; Xiong et al., 1999; Laube et al., 2000) . Within the glutamate and ATP receptor families, for example, some subtypes are modulated in a biphasic manner (showing potentiation, then inhibition as the Zn 2ϩ concentration is increased), whereas others are inhibited only by Zn 2ϩ . This is similar to what we have observed with neuronal nAChRs. The effects of Zn 2ϩ on NMDA-type glutamate receptors are particularly complex. Both voltage-dependent and voltage-independent inhibition as well as potentiation of NMDA receptors have been observed, depending on the particular receptor subunit combination, subunit splice variant, and Zn 2ϩ concentration (Mayer et al., 1989; Hollmann et al., 1993; Paoletti et al., 1997; Traynelis et al., 1998) .
Neuronal nAChRs have previously been shown to be potentiated by extracellular calcium (Mulle et al., 1992; Vernino et al., 1992) . Calcium exerts its potentiating effect on neuronal nAChRs by increasing the probability of channel opening (Amador and Dani, 1995) . Calcium appears to be bound by a series of EF-hand binding domains, and two critical glutamate residues on the ␣7 subunit have been identified (Galzi et al., 1996) . These glutamate residues, as well as other components of the putative EF-hand structures, are conserved in the ␣ and ␤ subunits used in our study. We think it is unlikely that Zn 2ϩ potentiation operates through these Ca 2ϩ binding sites for the following reasons. First, both ␣7 and ␣3␤2 receptors are potentiated by Ca 2ϩ and contain the putative EF-hand structures (Vernino et al., 1992; Galzi et al., 1996) but are not potentiated by Zn 2ϩ (Palma et al., 1998) (Fig.  2 B) . Second, the ability of DEPC and pH changes to reduce Zn 2ϩ potentiation (Figs. 5, 6 ) suggests the involvement of histidine residues in coordinating Zn 2ϩ . Histidines are not generally found in EF-hand Ca 2ϩ binding structures and are not present in the putative EF-hand structures in any of the subunits used in our study.
Neuronal nAChRs have also been shown to be modulated by various other agents. A group of compounds typified by physostigmine and galanthamine can activate exogenously expressed ␣4␤2 receptors and ␣7-containing receptors expressed in hippocampal neurons by interacting with an allosteric site distinct from the ACh binding site (Pereira et al., 1993 (Pereira et al., , 1994 Schrattenholz et al., 1996) . Lead inhibits ␣3␤4 and ␣4␤2 receptors at submicromolar concentrations and potentiates ␣3␤2 receptors at concentrations Ͼ100 M (Zwart et al., 1995) . Low concentrations (1-10 M) of (ϩ)-tubocurarine potentiate ␤4-containing receptors (␣2␤4 and ␣3␤4) while inhibiting ␤2-containing receptors (␣2␤2 and ␣3␤2) (Cachelin and Rust, 1994) . Atropine potentiates ␣4␤2 and ␣4␤4 receptors (but not ␣2␤2, ␣2␤4, ␣3␤2, or ␣3␤4 receptors) responding to low (1 M) ACh concentrations while inhibiting responses to high (1 mM) ACh concentrations (Zwart and Vijverberg, 1997) . The pattern of potentiation and inhibition of the various receptor subtypes seen with these agents varies markedly from what we have found with Zn 2ϩ , suggesting that Zn 2ϩ modulation of neuronal nAChRs is unrelated to modulation caused by these other agents.
We used DEPC to test for the involvement of histidine residues in Zn 2ϩ potentiation of nAChRs. Reaction of DEPC with histidine results in modification of the imidazole ring, rendering it incapable of coordinating Zn 2ϩ (Miles, 1977; Lundblad and Noyes, 1984) . A role for histidine residues in Zn 2ϩ modulation of glycine receptors has been revealed using this technique (Harvey et al., 1999) . DEPC can also affect arginine, lysine, cysteine, serine, and tyrosine residues when used under conditions of high concentration (Ն10 mM) and low pH (pH 4). However, under our conditions (Յ3 mM, pH 7.2), DEPC should be selective for histidine residues (Miles, 1977) . We found that Zn 2ϩ potentiation of neuronal nAChRs could be abolished by DEPC treatment. In contrast, Zn 2ϩ continued to inhibit ␣4␤4 and ␣3␤2 after DEPC treatment.
Histidine residues are also prevented from coordinating Zn 2ϩ by protonation of both imidazole nitrogens. The first pK a ranges from 6.0 to 6.5, depending on the local environment. If we assume a pK a of 6.25, then at pH 7.2 (our standard conditions), 89% of the imidazole rings would have an unprotonated nitrogen capable of coordinating Zn 2ϩ . Shifting the pH below the pK a would reduce the fraction of unprotonated histidines and should reduce histidine coordination of Zn 2ϩ . At pH 5.5, at which only 18% of histidines would be unprotonated, potentiation of ␣4␤4 was reduced to only 180 Ϯ 9% of ACh alone. At pH 8.0, at which 98% of histidine residues would be unprotonated, potentiation of ␣4␤4 increased to 770 Ϯ 70% of ACh alone. The sensitivity of Zn 2ϩ potentiation to both DEPC treatment and pH changes strongly suggests a role for histidine residues. These histidine residues may be involved in directly coordinating the Zn 2ϩ ion. However, we cannot rule out the possibility that DEPC and changes in pH are affecting a histidine within an allosteric pathway through which Zn 2ϩ might exert its potentiating effects. To approximate the location of the Zn 2ϩ binding sites in relation to the electric field of the membrane, we examined Zn 2ϩ potentiation and inhibition at several holding potentials (Fig. 7) . The degree of potentiation of ␣4␤4 receptors and inhibition of ␣3␤2 receptors remained constant across a range of holding potentials. This result suggests that potentiation and inhibition are not under the influence of the electric field of the membrane, and thus the relevant binding sites are not likely to be closely associated with the transmembrane domains of the receptor. We also examined the Zn 2ϩ sensitivity of receptors formed by chimeras of the ␣3 and ␣4 subunits (Fig. 9) . Results of these experiments suggest that determinants of Zn 2ϩ potentiation are located within the N-terminal extracellular domain, as well as in the remainder of the protein.
It is clear that both ␣ and ␤ subunits make contributions to Zn 2ϩ potentiation of neuronal nAChRs. (Shammat and Gordon, 1999) . At least two subunits contribute a histidine residue to form a single Ni 2ϩ site during the open state of the CNG channel (Gordon and Zagotta, 1995a,b) . If neuronal nAChRs have two Zn 2ϩ potentiation sites, the sites might be formed similarly to agonist binding sites (at the interface between two subunits). In either case, stabilization of the open state would explain our observation that Zn 2ϩ increases the response to saturating ACh concentrations.
Knowledge regarding the effect of Zn 2ϩ on neuronal nAChRs expressed in a neuronal context is limited. Nutter and Adams (1995) reported inhibition of ACh-evoked currents in cultured rat parasympathetic neurons. Although the neuronal nAChR subunit expression in these neurons is heterogeneous, the predominant subunits are ␣3, ␣7, and a varying ratio of ␤2 and ␤4 (Poth et al., 1996 (Poth et al., , 1997 . Thus, based on our results and the results of Palma et al., (1998) , many of the nAChRs expressed by these neurons would be expected to be inhibited by Zn 2ϩ . CNS synaptic terminals have been shown to be capable of taking up, storing, and releasing Zn 2ϩ (Huang, 1997; Frederickson et al., 2000) . Extracellular Zn 2ϩ is estimated to reach concentrations as high as several hundred micromolar during neuronal activity (Frederickson et al., 1983; Assaf and Chung, 1984) . Neuronal nAChRs are located both presynaptically and postsynaptically in many parts of the CNS and PNS. Our finding that Zn 2ϩ modulates neuronal nAChRs at concentrations that may be achieved in the nervous system suggests that Zn 2ϩ may affect synaptic activity through modulation of neuronal nAChRs.
